| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors
|
Miller, Eric J.
|
|
|
6 |
5 |
p. 1559-1565
|
article
|
| 2 |
Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation
|
Tey, Siok-Keen
|
|
|
6 |
5 |
p. 1619-1622
|
article
|
| 3 |
CAMK2G is identified as a novel therapeutic target for myelofibrosis
|
Miyauchi, Masashi
|
|
|
6 |
5 |
p. 1585-1597
|
article
|
| 4 |
Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
|
Grover, Punita
|
|
|
6 |
5 |
p. 1608-1618
|
article
|
| 5 |
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas
|
Koh, Min Jung
|
|
|
6 |
5 |
p. 1420-1431
|
article
|
| 6 |
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
|
Middeke, Jan M.
|
|
|
6 |
5 |
p. 1394-1405
|
article
|
| 7 |
Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma
|
Portell, Craig A.
|
|
|
6 |
5 |
p. 1490-1498
|
article
|
| 8 |
Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT
|
Mizuno, Kana
|
|
|
6 |
5 |
p. 1454-1463
|
article
|
| 9 |
Editorial Board
|
|
|
|
6 |
5 |
p. i
|
article
|
| 10 |
GATA2 deficiency elevates interferon regulatory factor-8 to subvert a progenitor cell differentiation program
|
Johnson, Kirby D.
|
|
|
6 |
5 |
p. 1464-1473
|
article
|
| 11 |
Impact of vitamin D level at diagnosis and transplantation on the prognosis of hematological malignancy: a meta-analysis
|
Ito, Yusuke
|
|
|
6 |
5 |
p. 1499-1511
|
article
|
| 12 |
Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice
|
Avellino, Roberto
|
|
|
6 |
5 |
p. 1406-1419
|
article
|
| 13 |
Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant
|
Chung, David J.
|
|
|
6 |
5 |
p. 1547-1558
|
article
|
| 14 |
M-CSFR/CSF1R signaling regulates myeloid fates in zebrafish via distinct action of its receptors and ligands
|
Hason, Martina
|
|
|
6 |
5 |
p. 1474-1488
|
article
|
| 15 |
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia
|
Fobare, Sydney
|
|
|
6 |
5 |
p. 1371-1380
|
article
|
| 16 |
Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation
|
Deeg, H. Joachim
|
|
|
6 |
5 |
p. 1623-1627
|
article
|
| 17 |
Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab
|
Wudhikarn, Kitsada
|
|
|
6 |
5 |
p. 1432-1443
|
article
|
| 18 |
Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study
|
Ali, Haris
|
|
|
6 |
5 |
p. 1444-1453
|
article
|
| 19 |
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
|
Haggenburg, Sabine
|
|
|
6 |
5 |
p. 1537-1546
|
article
|
| 20 |
SARS-CoV-2–neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma
|
Malin, Jakob J.
|
|
|
6 |
5 |
p. 1580-1584
|
article
|
| 21 |
SARS-CoV-2–specific T-cell responses to recurrent COVID-19 pneumonitis in a patient with post-CART B-cell aplasia
|
Hodder, Angus
|
|
|
6 |
5 |
p. 1577-1579
|
article
|
| 22 |
Sickle cell disease promotes sex-dependent pathological bone loss through enhanced cathepsin proteolytic activity in mice
|
Selma, Jada
|
|
|
6 |
5 |
p. 1381-1393
|
article
|
| 23 |
The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
|
Sacks, Naomi C.
|
|
|
6 |
5 |
p. 1566-1576
|
article
|
| 24 |
The molecular hallmarks of primary and secondary vitreoretinal lymphoma
|
Bonzheim, Irina
|
|
|
6 |
5 |
p. 1598-1607
|
article
|
| 25 |
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT
|
Shouval, Roni
|
|
|
6 |
5 |
p. 1525-1535
|
article
|
| 26 |
Tiong IS, Dillon R, Ivey A, et al. Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia. Blood Adv. 2021;5(23):5107-5111.
|
|
|
|
6 |
5 |
p. 1489
|
article
|
| 27 |
Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
|
Chiesa, Robert
|
|
|
6 |
5 |
p. 1512-1524
|
article
|
| 28 |
Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.
|
|
|
|
6 |
5 |
p. 1536
|
article
|
Journal description